Solution structure of dynorphin a (1-17): A NMR study in a cryoprotective solvent mixture at 278 K

Journal of Peptide Science

Volumn 5, Issue 7, 1999, Pages 306-312

  Spadaccini, Roberta ^a,c   Crescenzi, Orlando ^b   Picone, Delia ^b   Tancredi, Teodorico ^a,c   Temussi, Piero Andrea ^b  

^a CNR   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c Natl Inst the Chem of Biol Syst   (Italy)

Author keywords

Cryoprotective mixture; Dynorphin A; Linear peptides; NMR structure; Opioid peptides

Indexed keywords

ACETONITRILE; AMINO ACID; CRYOPROTECTIVE AGENT; DIMETHYL SULFOXIDE; DYNORPHIN A; ENKEPHALIN; HEXAFLUOROACETONE; KAPPA OPIATE RECEPTOR; METHANOL; OPIATE AGONIST;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN STRUCTURE;

AMINO ACID SEQUENCE; COLD; DYNORPHINS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR SEQUENCE DATA; PROTEIN CONFORMATION; RECEPTORS, OPIOID; RECEPTORS, OPIOID, KAPPA; RECEPTORS, OPIOID, MU; SOLUTIONS; SOLVENTS;

EID: 0032794545     PISSN: 10752617     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1387(199907)5:7<306::AID-PSC199>3.0.CO;2-B     Document Type: Article

References (39)

1. Goldstein A, Tachibana S, Lownej LI, Hunkapiller M, Hood L. Dynorphin-(1-13), an extraordinarily potent opioid peptide. Proc Natl Acad Sci USA 1979; 76: 6666-6670.
2. Lord JAH, Waterfield AA, Hughes J, Kosterlitz HW. Endogenous opioid peptides: multiple agonists and receptors. Nature 1977; 267: 495-499.
3. Okuda-Ashitaka E, Toshiaki M, Tachibana S, Yoshihara Y, Nishiuchi Y, Kimura T, Ito S. Nocistatin, a peptide that blocks nociceptin action in pain transmission. Nature 1998; 392: 286-289.
4. Pan ZZ, Tershner SA, Fields HL. Cellular mechanism for anti-analgesic action of agonists of the k-opioid receptor. Nature 1997; 389: 382-385.
5. Kallick D. Conformation of Dynorphin A (1-17) bound to dodecylphosphocholine micelles. J Am Chem Soc 1993; 115: 9317-9318.
6. Tessmer MR, Kallick DB. NMR and structural model of dynorphin A (1-17) bound to dodecylphosphocholine micelles. Biochemistry 1997; 36: 1971-1981.
7. Vaughn JB, Taylor JW. Proton NMR and CD solution conformation determination and opioid receptor binding studies of a dynorphln A (1-17) model peptide. Biochem Biophys Acta 1989; 999: 135-146.
8. 1H nuclear magnetic resonance study of the opioid peptide dynorphin-(1-13) in aqueous solution. J Chem Soc, Perkin Trans II 1986; 637-644.
9. Lancaster CRD, Mishra PK, Hughes DW, St.-Pierre SA, Bothner-By AA, Epand RM. Mimicking the membrane-mediated conformation of dynorphin A (1-13) peptide: circular dichroism and nuclear magnetic resonance studies in methanolic solution. Biochemistry 1991; 30: 4715-4726.
10. Schwyzer R. Molecular mechanism of opioid receptor selection. Biochemistry 1986; 25: 4281-4286.
11. Wang JB, Johnson PS, Wu JM, Wang WF, Uhl GR. Human κ opiate receptor second extracellular loop elevates dynorphin's affinity for human μ/κ chimeras. J Biol Chem 1994; 269: 25966-25969.
12. Xue C, Zhu J, Chen C, Kunapuli S, DeRiel J, Liu-Chen LY. Differential binding domains of peptide and nonpeptide ligands in the cloned rat κ opioid receptor. J Biol Chem 1994; 269: 30195-30199.
13. Meunier JC, Mollerau C, Toll L, Suaudeau C, Moisand C, Alvinerie P, Butuour JL, Guillemot JC, Ferrara P, Monsarrat B, Mazargull H, Vassart G, Parmentier M, Costentin J. Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature 1995; 377: 532-535.
14. Mollerau C, Parmentier M, Mailleux P, Butuour JL, Moisand C, Chalon P, Caput D, Vassart G, Meunier JC. ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization. FEBS Lett 1994; 341: 33-38.
15. Bax A, Davis DG. Practical aspects of two-dimensional transverse NOE spectroscopy. J Magn Reson 1985; 63: 207-213.
16. Jeener J, Meyer BH, Bachman P, Ernst RR. Investigation of exchange processes by two-dimensional NMR spectroscopy. J Chem Phys 1979; 71: 4546-4553.
17. 1H spin-spin coupling constants in proteins. Biochem Biophys Res Commun 1983; 113: 967-971.
18. Güntert P, Mumenthaler C, Wüthrich K. Torsion angle dynamics for NMR structure calculation with the new program DYANA. J Mol Biol 1997; 273: 283-298.
19. Weiner SJ, Kollman PA, Case DA, Singh UC, Ghio C, Alagona G, Profeta S, Weiner P. A new force field for molecular mechanical simulation of nucleic acids and proteins. J Am Chem Soc 1984; 106: 765-784.
20. Pearlman DA, Case DA, Caldwell JW, Ross WR, Cheatham III TE, DeBolt S, Ferguson D, Seibel G, Kollman P. AMBER, a computer program for applying molecular mechanics, normal mode analysis, molecular dynamics and free energy calculations to elucidate the structures and energies of molecules. Comput Phys Commun 1995; 91: 1-41.
21. 1H-NMR study in methanol. Eur J Biochem 1988; 173: 139-146.
22. Marion D, Zasloff M, Bax A. A two-dimensional NMR study of the antimicrobial peptide magainin 2. FEBS Lett 1988; 227: 21-26.
23. Sonnichsen, FD, Van Eyk JE, Hodges RS, Sykes BD. Effect of trifluoroethanol on protein secondary structure: an NMR and CD study using a synthetic actin peptide. Biochemistry 1992; 31: 8790-8798.
24. Verheyden P, De Wolf E, Jaspers H, Van Binst G. Comparing conformations at low temperature and at high viscosity. Conformational study of somatostatin and two of its analogues in methanol and in ethylene glycol. Int J Pept Protein Res 1994; 44: 401-409.
25. Reymond MT, Huo S, Duggan B, Wright PE, Dyson HJ. Contribution of increased length and intact capping sequences to the conformatlonal preference for helix in a 31-residue peptide from the C-terminus of myohemerythrin. Biochemistry 1997; 36: 5234-5244.
26. Rajan R, Awasthi SK, Bhattachajya S, Balaram P. Teflon-coated peptides: hexafluoroacetone trihydrate as a structure stabilizer for peptides. Biopolymers 1997; 42: 125-128.
27. Pollard EC. in: The Aqueous Cytoplasm. A.D. Keith Ed., p. 1-22, Dekker, New York, 1979.
28. Chapmann D, Peel WE. in: The Aqueous Cytoplasm, A.D. Keith Ed., p. 137-178, Dekker, New York, 1979.
29. Douzou P, Petsko GA. Proteins at work: 'stop-action' pictures at subzero temperatures. Adv Protein Chem 1984; 36: 245-361.
30. Fink AL. Protein folding in cryosolvents and at subzero temperatures. Methods Enzymol 1986; 131: 173-187.
31. 13C] acetyl-chymotrypsin dissolved in a cryosolvent at subzero temperatures. J Magn Reson 1986; 68: 381-385.
32. Amodeo P, Motta A, Picone D, Saviano G, Tancredi T, Temussi PA. Viscosity as a conformational sieve. NOE of linear peptides in cryoprotective mixtures. J Magn Reson 1991; 95: 201-207.
33. Wüthrich K. in: NMR of Proteins and Nucleic Acids, p. 162-175, Wiley, New York, 1986.
34. 1H NMR. Eur J Biochem 1990; 192: 433-439.
35. 15N-Leu-enkephalin. J Pept Sci 1998; 4: 253-265.
36. Deschamps JR, George C, Flippen-Anderson JL. Structural studies of opioid peptides: a review of recent progress in X-ray diffraction studies. Biopolymers (Pept Sci) 1996; 40: 121-139.
37. Salvadori S, Picone D, Tancredi T, Guerrini R, Spadaccini R, Lazarus LH, Regoli D, Temussi PA. Comparison between the conformational state and biological function of nociceptin and dynorphin A. Biochem Biophys Res Commun 1997; 233: 640-643.
38. Chavkin C, Goldstein A. Specific receptor for the opioid peptide dynorphin: structure-activity relationships. Proc Natl Acad Sci USA 1981; 78: 6543-6547.
39. Paterlini G, Portoghese PS, Ferguson DM. Molecular simulation of dynorphin A-(1-10) binding to extracellular loop 2 of the kappa-opioid receptor. A model for receptor activation. J Med Chem 1997; 40: 3254-3262.